News

Formal statement on the forthcoming US Brainstorm trial

Statement on Future U.S. BrainStorm Clinical Trial

30/Jan/2014

We have had many inquiries regarding the BrainStorm Stem Cell Therapeutics Clinical Trial. BrainStorm is currently conducting a Phase IIa dose-escalating trial at the Hadassah Medical Center in Israel. We are working with BrainStorm on a planned Phase II study in the U.S. and hope to begin the trial this year. We are continuing to follow the progress of the study in Israel and will keep the NEALS website current on all new trials and start dates.

Protocol information and eligibility criteria for the BrainStorm trial have been posted on the US Government's clinical trials website. Please note, however, that the study has not yet been approved by the FDA, and recruitment has not started. Please continue to check here for new developments about this trial.

patient

U.S. News and World Report Best Hospitals 2013-2014

U.S. News & World Report ranks Mass General #2 in the nation and #1 in New England based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.